首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Phase II study of MTOR-inhibitor RAD001 and erlotinib for advanced, gemcitabine-refractory pancreatic cancer
被引:0
作者
:
Javle, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
Javle, M.
[
1
]
Fogelman, D.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
Fogelman, D.
[
1
]
Kaseb, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
Kaseb, A.
[
1
]
Varadhachary, G.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
Varadhachary, G.
[
1
]
Wolff, R.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
Wolff, R.
[
1
]
Abbruzzese, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
Abbruzzese, J.
[
1
]
机构
:
[1]
Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源
:
EJC SUPPLEMENTS
|
2008年
/ 6卷
/ 12期
关键词
:
D O I
:
10.1016/S1359-6349(08)72262-6
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
引用
收藏
页码:104 / 104
页数:1
相关论文
未找到相关数据
未找到相关数据